Tybourne Capital Management’s LianBio American Depositary Shares LIAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,398,890
Closed -$15.2M 42
2023
Q4
$15.2M Buy
3,398,890
+95,317
+3% +$328K 2.26% 17
2023
Q3
$4.92M Hold
3,303,573
0.69% 17
2023
Q2
$7.53M Hold
3,303,573
0.81% 21
2023
Q1
$6.48M Hold
3,303,573
0.65% 23
2022
Q4
$5.42M Hold
3,303,573
0.54% 25
2022
Q3
$6.61M Sell
3,303,573
-10,600
-0.3% -$25.4K 0.64% 25
2022
Q2
$7.16M Hold
3,314,173
0.52% 26
2022
Q1
$12.3M Hold
3,314,173
0.73% 25
2021
Q4
$20.4M Buy
+3,314,173
New +$37.9M 0.61% 21

Other funds holding LIAN

Tybourne Capital Management's LIAN Position: Q1 2024 in Review

Tybourne Capital Management sold out of LianBio American Depositary Shares (LIAN) in Q1 2024, closing a stake of 3,398,890 shares — an estimated $15.2M sold.

Tybourne Capital Management first reported a position in LIAN in Q4 2021 and held it in 9 quarters. The position peaked at $20.4M in Q4 2021. 3 funds tracked by Wall St. Rank hold LIAN as of Q1 2024.

  • Tybourne Capital Management reported no remaining LianBio American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Tybourne Capital Management sold 3,398,890 LianBio American Depositary Shares shares in Q1 2024, an estimated $15.2M.
  • Tybourne Capital Management first reported a position in LianBio American Depositary Shares in Q4 2021 and held it in 9 quarters.
  • Tybourne Capital Management's LianBio American Depositary Shares position peaked at $20.4M in Q4 2021.
  • 3 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2024.

Based on Tybourne Capital Management's 13F filing for Q1 2024, filed 15 May 2024.